The bone morphogenic protein inhibitor, noggin, reduces glycemia and vascular inflammation in db/db mice. [electronic resource]
Producer: 20140204Description: H747-55 p. digitalISSN:- 1522-1539
- Angiotensin II Type 1 Receptor Blockers -- pharmacology
- Animals
- Blood Glucose -- drug effects
- Blood Pressure -- drug effects
- Bone Morphogenetic Proteins -- antagonists & inhibitors
- Carrier Proteins -- pharmacology
- Diabetes Mellitus, Type 2 -- complications
- Disease Models, Animal
- Hyperglycemia -- physiopathology
- Male
- Mice
- Mice, Mutant Strains
- Reactive Oxygen Species -- metabolism
- Tetrazoles -- pharmacology
- Valine -- analogs & derivatives
- Valsartan
- Vasculitis -- physiopathology
No physical items for this record
Publication Type: Comparative Study; Journal Article; Research Support, N.I.H., Extramural
There are no comments on this title.
Log in to your account to post a comment.